TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial.

Yelena Y Janjigian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.